Johnson Pharmacare Ltd Financials

Johnson Pharmacare Ltd Financial Statement

Johnson Pharmacare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	TBA	TBA	TBA
Operating Expense	TBA	0.04	TBA
Net Profit	TBA	-0.04	TBA
Net Profit Margin	TBA	TBA	TBA
Earning Per Share	TBA	TBA	TBA
EBIDTA	TBA	-0.04	TBA
Effective Tax Rate	TBA	TBA	TBA

Particulars	Sep 2024
Revenue	TBA
Operating Expense	TBA
Net Profit	TBA
Net Profit Margin	TBA
Earning Per Share	TBA
EBIDTA	TBA
Effective Tax Rate	TBA

Johnson Pharmacare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	TBA	2.53	3.26
Operating Expenses Annual	0.20	3.86	3.13
Operating Profit Annual	-0.20	-1.33	0.13
Interest Annual	TBA	TBA	TBA
Depreciation	TBA	TBA	TBA
Net Profit Annual	-0.20	-1.29	0.10
Tax Annual	TBA	-0.04	0.04

Particulars	Mar 2024
Total Revenue Annual	TBA
Operating Expenses Annual	0.20
Operating Profit Annual	-0.20
Interest Annual	TBA
Depreciation	TBA
Net Profit Annual	-0.20
Tax Annual	TBA

Johnson Pharmacare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	TBA	0.04	0.23
Cash Flow from Operations	-0.05	-0.40	4.90
Cash Flow from Investing	TBA	-0.94	-5.01
Cash Flow from Financing	0.05	1.30	-0.08
Cash Flow at the End	TBA	TBA	0.04

Particulars	Mar 2024
Cash Flow at the Beginning	TBA
Cash Flow from Operations	-0.05
Cash Flow from Investing	TBA
Cash Flow from Financing	0.05
Cash Flow at the End	TBA

Johnson Pharmacare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	TBA	8.70	3.99
PBIT Margin (%)	TBA	8.70	3.99
PBT Margin (%)	TBA	8.70	3.99
Net PROFIT Margin (%)	TBA	-50.99	3.07
Return On Networth / Equity (%)	TBA	TBA	0.17
Return On Networth /Employed (%)	TBA	TBA	0.24
Return On Assets (%)	TBA	-2.04	0.18
Total Debt / Equity (X)	0.03	0.02	0.01
Asset Turnover Ratio (%)	TBA	0.04	0.06

Particulars	Mar 2024
PBDIT Margin (%)	TBA
PBIT Margin (%)	TBA
PBT Margin (%)	TBA
Net PROFIT Margin (%)	TBA
Return On Networth / Equity (%)	TBA
Return On Networth /Employed (%)	TBA
Return On Assets (%)	TBA
Total Debt / Equity (X)	0.03
Asset Turnover Ratio (%)	TBA

Johnson Pharmacare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	TBA	TBA	TBA
Total Current Assets Annual	0.00	0.00	1.09
Non Current Assets Annual	59.83	59.83	58.89
Total Shareholders Funds Annual	56.75	56.95	58.24
Total Assets Annual	59.83	59.83	59.98

Particulars	Mar 2024
Fixed Assets Annual	TBA
Total Current Assets Annual	0.00
Non Current Assets Annual	59.83
Total Shareholders Funds Annual	56.75
Total Assets Annual	59.83

Johnson Pharmacare Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 9, 2024, Johnson Pharmacare Ltd has a market capitalization of 37.95 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Johnson Pharmacare Ltd is debt-free with a debt-to-equity ratio of 0.03.

In FY 2023 , Johnson Pharmacare Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

Johnson Pharmacare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.3% and -100.0% annually, respectively..

Johnson Pharmacare Ltd's current PE ratio is -189.75.

Johnson Pharmacare Ltd's ROCE averaged -0.8% from the FY ending March 2022 to 2024, with a median of -0.3%. It peaked at 0.2% in March 2022, reflecting strong capital efficiency over the period..

Johnson Pharmacare Ltd's latest EBIT is Rs. -0.20 Cr, surpassing the average EBIT of Rs. -0.45 Cr over the 5 years..